PINK COPYRIGHT: A GROWING DANGER?

A alarming development is emerging within the substance scene: "Pink copyright," formally known as Flunitramadol. This synthetic opioid is being sold as a crystal , often presented as copyright, posing a significant risk to people. Its deceptively low price and simple accessibility are contributi